You can’t be in Chicago and miss the blues and thanks to the IL pavilion we had some awesome blues.
This band performed at the trade show reception. I wish I knew who they are.
If you’d like to know what they sound like I shot a short video clip of the which you can watch here:
IL Blues (2 min wmv)


My home state is well represented here at BIO.
Besides our own domestic ag journalists there has been a large (larger) contingent of foreign ag journalists.
It’s always fun trying to keep posts at a conference in some sort of chronological order. But it just never works out that way. Here’s Orion Samuelson, doing an interview with one of the visiting ag journalists at the U. S. Grains Council/IL Corn Growers event. I was glad to see Orion here since there really hasn’t been many U. S. ag reporters.
The plenary breakfast speaker today, R. James Woolsey, Vice President, Booz Allen Hamilton, Former Director of the Central Intelligence Agency, just finished speaking. He really focused on how biotechnology can play a role in our national security. Besides what most people probably think of first in terms of cures or innoculants for bio-terror induced disease he spent a while talking about energy and independence from terrorist controlled foreign oil.

I’m just can’t get over how many companies are giving away iPods here.
Last night Illinois farmer, banker, ethanol plant CEO and RFA board member Ray Defenbaugh was one of several people who spoke to a group of visiting agricultural journalists during a media reception sponsored by the
It’s just about reception time here at BIO. I’m going to have to sign off for a while and make the rounds. These people are in the British Columbia pavilion with some flavored shooters for the upcoming trade show reception.
Ernst & Young publishes an annual report on the biotechnology industry. The latest edition was just announced, titled,
agriculture, which they call the “second wave” of biotech. It does and he says they’ve brought back industry breakout charts which are even done by country so you can compare how different countries have been focusing on different segments of the biotech business. You can hear the answer here: